International tumor board weighs personalized options for colon cancer with no measurable disease
A case report in Oncotarget describes how an international molecular tumor board weighed treatment options for a 52-year-old woman with ...
A case report in Oncotarget describes how an international molecular tumor board weighed treatment options for a 52-year-old woman with ...
A new Oncotarget case report details how the WIN Consortium's international molecular tumor board evaluated investigational EGFR, MDM2, CDK4/6 and ...
Laura J. Tafe, M.D., a professor of pathology and laboratory medicine at Dartmouth Hitchcock Medical Center and the Geisel School ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine